# Prime Medicine Appoints Matthew Hawryluk, Ph.D., M.B.A. as Chief Business Officer
Canonical URL: https://biopharmsignal.com/news/PRME/prime-medicine-appoints-matthew-hawryluk-ph-d-m-b-a-as-chief-business-officer
Ticker: PRME
Company: Prime Medicine
Source: Prime Medicine
Published: 2025-11-03 13:01 EST
Original Source URL: https://investors.primemedicine.com
## Summary

CAMBRIDGE, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the appointment of Matthew Hawryluk, Ph.D., M.B.A.

## Article Body
CAMBRIDGE, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the appointment of Matthew Hawryluk, Ph.D., M.B.A.
## Recent Company News
- 2026-06-03 12:00 EST — [Prime Medicine to Present at Goldman Sachs 47th Annual Global Healthcare Conference](https://biopharmsignal.com/news/PRME/prime-medicine-to-present-at-goldman-sachs-47th-annual-global-healthcare-conference) — Source: Prime Medicine
- 2026-05-07 12:00 EST — [Prime Medicine Reports First Quarter 2026 Financial Results and Provides Business Updates](https://biopharmsignal.com/news/PRME/prime-medicine-reports-first-quarter-2026-financial-results-and-provides-business-updates) — Source: Prime Medicine
- 2026-04-16 12:00 EST — [Prime Medicine Appoints Svetlana Makhni as Chief Financial Officer](https://biopharmsignal.com/news/PRME/prime-medicine-appoints-svetlana-makhni-as-chief-financial-officer) — Source: Prime Medicine
- 2026-03-03 13:00 EST — [Prime Medicine Reports Full Year 2025 Financial Results and Provides Business Updates](https://biopharmsignal.com/news/PRME/prime-medicine-reports-full-year-2025-financial-results-and-provides-business-updates) — Source: Prime Medicine
- 2026-02-25 13:00 EST — [Prime Medicine to Participate in Upcoming Investor Conferences](https://biopharmsignal.com/news/PRME/prime-medicine-to-participate-in-upcoming-investor-conferences) — Source: Prime Medicine
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)